Logo image of GBLB.BR

GROUPE BRUXELLES LAMBERT NV (GBLB.BR) Stock Fundamental Analysis

Europe - Euronext Brussels - EBR:GBLB - BE0003797140 - Common Stock

74.55 EUR
+0.6 (+0.81%)
Last: 11/28/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, GBLB scores 3 out of 10 in our fundamental rating. GBLB was compared to 53 industry peers in the Financial Services industry. GBLB has an average financial health and profitability rating. GBLB does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

GBLB had positive earnings in the past year.
In the past year GBLB had a positive cash flow from operations.
GBLB had positive earnings in 4 of the past 5 years.
In the past 5 years GBLB always reported a positive cash flow from operatings.
GBLB.BR Yearly Net Income VS EBIT VS OCF VS FCFGBLB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

1.2 Ratios

GBLB has a Return On Assets (0.52%) which is comparable to the rest of the industry.
The Return On Equity of GBLB (1.07%) is comparable to the rest of the industry.
With a Return On Invested Capital value of 0.96%, GBLB is not doing good in the industry: 60.38% of the companies in the same industry are doing better.
GBLB had an Average Return On Invested Capital over the past 3 years of 0.81%. This is significantly below the industry average of 8.63%.
The 3 year average ROIC (0.81%) for GBLB is below the current ROIC(0.96%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.52%
ROE 1.07%
ROIC 0.96%
ROA(3y)1.59%
ROA(5y)1.37%
ROE(3y)2.81%
ROE(5y)2.38%
ROIC(3y)0.81%
ROIC(5y)1.13%
GBLB.BR Yearly ROA, ROE, ROICGBLB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

GBLB's Profit Margin of 1.98% is in line compared to the rest of the industry. GBLB outperforms 45.28% of its industry peers.
GBLB's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 5.49%, GBLB is not doing good in the industry: 60.38% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of GBLB has declined.
Looking at the Gross Margin, with a value of 62.71%, GBLB is in the better half of the industry, outperforming 66.04% of the companies in the same industry.
GBLB's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.49%
PM (TTM) 1.98%
GM 62.71%
OM growth 3Y-18.48%
OM growth 5Y-18.66%
PM growth 3Y-21.26%
PM growth 5Y-30.86%
GM growth 3Y-5.44%
GM growth 5Y-0.69%
GBLB.BR Yearly Profit, Operating, Gross MarginsGBLB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GBLB is destroying value.
The number of shares outstanding for GBLB has been reduced compared to 1 year ago.
The number of shares outstanding for GBLB has been reduced compared to 5 years ago.
The debt/assets ratio for GBLB is higher compared to a year ago.
GBLB.BR Yearly Shares OutstandingGBLB.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
GBLB.BR Yearly Total Debt VS Total AssetsGBLB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

GBLB has an Altman-Z score of 1.31. This is a bad value and indicates that GBLB is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.31, GBLB is in line with its industry, outperforming 47.17% of the companies in the same industry.
GBLB has a debt to FCF ratio of 12.98. This is a negative value and a sign of low solvency as GBLB would need 12.98 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 12.98, GBLB is in line with its industry, outperforming 47.17% of the companies in the same industry.
GBLB has a Debt/Equity ratio of 0.51. This is a neutral value indicating GBLB is somewhat dependend on debt financing.
GBLB has a Debt to Equity ratio (0.51) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF 12.98
Altman-Z 1.31
ROIC/WACC0.16
WACC5.94%
GBLB.BR Yearly LT Debt VS Equity VS FCFGBLB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

A Current Ratio of 1.91 indicates that GBLB should not have too much problems paying its short term obligations.
GBLB's Current ratio of 1.91 is fine compared to the rest of the industry. GBLB outperforms 69.81% of its industry peers.
GBLB has a Quick Ratio of 1.56. This is a normal value and indicates that GBLB is financially healthy and should not expect problems in meeting its short term obligations.
GBLB has a better Quick ratio (1.56) than 67.92% of its industry peers.
Industry RankSector Rank
Current Ratio 1.91
Quick Ratio 1.56
GBLB.BR Yearly Current Assets VS Current LiabilitesGBLB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2

3. Growth

3.1 Past

GBLB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -91.95%.
The earnings per share for GBLB have been decreasing by -26.51% on average. This is quite bad
Looking at the last year, GBLB shows a decrease in Revenue. The Revenue has decreased by -1.53% in the last year.
Measured over the past years, GBLB shows a small growth in Revenue. The Revenue has been growing by 3.51% on average per year.
EPS 1Y (TTM)-91.95%
EPS 3Y-18.6%
EPS 5Y-26.51%
EPS Q2Q%-23.15%
Revenue 1Y (TTM)-1.53%
Revenue growth 3Y-0.95%
Revenue growth 5Y3.51%
Sales Q2Q%1.86%

3.2 Future

GBLB is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -6.19% yearly.
Based on estimates for the next years, GBLB will show a small growth in Revenue. The Revenue will grow by 2.33% on average per year.
EPS Next Y-28.35%
EPS Next 2Y-11.43%
EPS Next 3Y-6.19%
EPS Next 5YN/A
Revenue Next Year0.99%
Revenue Next 2Y1.99%
Revenue Next 3Y2.33%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
GBLB.BR Yearly Revenue VS EstimatesGBLB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
GBLB.BR Yearly EPS VS EstimatesGBLB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 77.66, GBLB can be considered very expensive at the moment.
Based on the Price/Earnings ratio, GBLB is valued a bit more expensive than 64.15% of the companies in the same industry.
When comparing the Price/Earnings ratio of GBLB to the average of the S&P500 Index (26.31), we can say GBLB is valued expensively.
Based on the Price/Forward Earnings ratio of 21.34, the valuation of GBLB can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of GBLB is on the same level as its industry peers.
GBLB is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 36.56, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 77.66
Fwd PE 21.34
GBLB.BR Price Earnings VS Forward Price EarningsGBLB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

60.38% of the companies in the same industry are more expensive than GBLB, based on the Enterprise Value to EBITDA ratio.
GBLB's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 16.86
EV/EBITDA 12.99
GBLB.BR Per share dataGBLB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

A cheap valuation may be justified as GBLB's earnings are expected to decrease with -6.19% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.43%
EPS Next 3Y-6.19%

5

5. Dividend

5.1 Amount

GBLB has a Yearly Dividend Yield of 4.73%, which is a nice return.
Compared to an average industry Dividend Yield of 3.41, GBLB pays a better dividend. On top of this GBLB pays more dividend than 83.02% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, GBLB pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.73%

5.2 History

The dividend of GBLB decreases each year by -2.00%.
Dividend Growth(5Y)-2%
Div Incr Years1
Div Non Decr Years4
GBLB.BR Yearly Dividends per shareGBLB.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

GBLB pays out 468.18% of its income as dividend. This is not a sustainable payout ratio.
GBLB's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP468.18%
EPS Next 2Y-11.43%
EPS Next 3Y-6.19%
GBLB.BR Yearly Income VS Free CF VS DividendGBLB.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B
GBLB.BR Dividend Payout.GBLB.BR Dividend Payout, showing the Payout Ratio.GBLB.BR Dividend Payout.PayoutRetained Earnings

GROUPE BRUXELLES LAMBERT NV

EBR:GBLB (11/28/2025, 7:00:00 PM)

74.55

+0.6 (+0.81%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)11-06 2025-11-06
Earnings (Next)03-12 2026-03-12
Inst Owners25.81%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap9.93B
Revenue(TTM)6.68B
Net Income(TTM)132.30M
Analysts83.08
Price Target86.32 (15.79%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.73%
Yearly Dividend2.78
Dividend Growth(5Y)-2%
DP468.18%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.99%
PT rev (3m)0.99%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 77.66
Fwd PE 21.34
P/S 1.49
P/FCF 16.86
P/OCF 8.24
P/B 0.8
P/tB 1.89
EV/EBITDA 12.99
EPS(TTM)0.96
EY1.29%
EPS(NY)3.49
Fwd EY4.69%
FCF(TTM)4.42
FCFY5.93%
OCF(TTM)9.05
OCFY12.14%
SpS50.19
BVpS92.77
TBVpS39.46
PEG (NY)N/A
PEG (5Y)N/A
Graham Number44.76
Profitability
Industry RankSector Rank
ROA 0.52%
ROE 1.07%
ROCE 1.63%
ROIC 0.96%
ROICexc 1.13%
ROICexgc 1.79%
OM 5.49%
PM (TTM) 1.98%
GM 62.71%
FCFM 8.81%
ROA(3y)1.59%
ROA(5y)1.37%
ROE(3y)2.81%
ROE(5y)2.38%
ROIC(3y)0.81%
ROIC(5y)1.13%
ROICexc(3y)0.92%
ROICexc(5y)1.25%
ROICexgc(3y)1.32%
ROICexgc(5y)1.66%
ROCE(3y)1.37%
ROCE(5y)1.91%
ROICexgc growth 3Y-6.63%
ROICexgc growth 5Y-8.4%
ROICexc growth 3Y-11.16%
ROICexc growth 5Y-11.6%
OM growth 3Y-18.48%
OM growth 5Y-18.66%
PM growth 3Y-21.26%
PM growth 5Y-30.86%
GM growth 3Y-5.44%
GM growth 5Y-0.69%
F-Score5
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF 12.98
Debt/EBITDA 6.63
Cap/Depr 104.99%
Cap/Sales 9.21%
Interest Coverage 0.96
Cash Conversion 126.32%
Profit Quality 445.28%
Current Ratio 1.91
Quick Ratio 1.56
Altman-Z 1.31
F-Score5
WACC5.94%
ROIC/WACC0.16
Cap/Depr(3y)97.68%
Cap/Depr(5y)87.97%
Cap/Sales(3y)10%
Cap/Sales(5y)8.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-91.95%
EPS 3Y-18.6%
EPS 5Y-26.51%
EPS Q2Q%-23.15%
EPS Next Y-28.35%
EPS Next 2Y-11.43%
EPS Next 3Y-6.19%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.53%
Revenue growth 3Y-0.95%
Revenue growth 5Y3.51%
Sales Q2Q%1.86%
Revenue Next Year0.99%
Revenue Next 2Y1.99%
Revenue Next 3Y2.33%
Revenue Next 5YN/A
EBIT growth 1Y-41.9%
EBIT growth 3Y-19.25%
EBIT growth 5Y-15.81%
EBIT Next Year9.24%
EBIT Next 3Y5.06%
EBIT Next 5YN/A
FCF growth 1Y82.78%
FCF growth 3Y8.34%
FCF growth 5Y2.47%
OCF growth 1Y13.85%
OCF growth 3Y8.48%
OCF growth 5Y4.55%

GROUPE BRUXELLES LAMBERT NV / GBLB.BR FAQ

What is the ChartMill fundamental rating of GROUPE BRUXELLES LAMBERT NV (GBLB.BR) stock?

ChartMill assigns a fundamental rating of 3 / 10 to GBLB.BR.


What is the valuation status of GROUPE BRUXELLES LAMBERT NV (GBLB.BR) stock?

ChartMill assigns a valuation rating of 2 / 10 to GROUPE BRUXELLES LAMBERT NV (GBLB.BR). This can be considered as Overvalued.


What is the profitability of GBLB stock?

GROUPE BRUXELLES LAMBERT NV (GBLB.BR) has a profitability rating of 4 / 10.


What are the PE and PB ratios of GROUPE BRUXELLES LAMBERT NV (GBLB.BR) stock?

The Price/Earnings (PE) ratio for GROUPE BRUXELLES LAMBERT NV (GBLB.BR) is 77.66 and the Price/Book (PB) ratio is 0.8.


How financially healthy is GROUPE BRUXELLES LAMBERT NV?

The financial health rating of GROUPE BRUXELLES LAMBERT NV (GBLB.BR) is 4 / 10.